{
    "ticker": "EVEX.WS",
    "name": "Evoke Pharma, Inc.",
    "description": "Evoke Pharma, Inc. is a biopharmaceutical company focused on developing novel treatments for gastrointestinal disorders. Established in 2010, Evoke is committed to advancing the therapeutic landscape for patients suffering from conditions like gastroparesis, a disorder that affects the stomach muscles and prevents proper stomach emptying. The company\u2019s lead product candidate, Gimoti, is a nasal spray formulation of metoclopramide designed to provide rapid relief of symptoms associated with gastroparesis. This innovative delivery method aims to enhance patient compliance and improve therapeutic outcomes. Evoke\u2019s research is driven by a strong scientific foundation and a deep understanding of gastrointestinal physiology, positioning the company to address unmet medical needs in this area. The company is also exploring additional product candidates to expand its pipeline and offers solutions for other gastrointestinal conditions. With a dedicated team and strategic partnerships, Evoke aims to bring meaningful advancements to the field of gastroenterology, ultimately improving the quality of life for patients dealing with debilitating symptoms.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2010",
    "website": "https://www.evokepharma.com",
    "ceo": "David Gonyer",
    "social_media": {
        "twitter": "https://twitter.com/EvokePharma",
        "linkedin": "https://www.linkedin.com/company/evoke-pharma/"
    },
    "investor_relations": "https://investors.evokepharma.com",
    "key_executives": [
        {
            "name": "David Gonyer",
            "position": "CEO"
        },
        {
            "name": "Dawn W. K. M. B. G. C. J. King",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Gimoti"
            ]
        }
    ],
    "seo": {
        "meta_title": "Evoke Pharma, Inc. | Novel Treatments for Gastrointestinal Disorders",
        "meta_description": "Evoke Pharma, Inc. is dedicated to developing innovative treatments for gastrointestinal disorders like gastroparesis. Learn about Gimoti and our commitment to patient care.",
        "keywords": [
            "Evoke Pharma",
            "Gastrointestinal Disorders",
            "Gastroparesis",
            "Biopharmaceuticals",
            "Gimoti"
        ]
    },
    "faq": [
        {
            "question": "What is Evoke Pharma known for?",
            "answer": "Evoke Pharma is known for developing Gimoti, a nasal spray for treating gastroparesis."
        },
        {
            "question": "Who is the CEO of Evoke Pharma?",
            "answer": "David Gonyer is the CEO of Evoke Pharma, Inc."
        },
        {
            "question": "Where is Evoke Pharma headquartered?",
            "answer": "Evoke Pharma is headquartered in San Diego, California, USA."
        },
        {
            "question": "What is Gimoti?",
            "answer": "Gimoti is a nasal spray formulation of metoclopramide for the treatment of gastroparesis."
        },
        {
            "question": "When was Evoke Pharma founded?",
            "answer": "Evoke Pharma was founded in 2010."
        }
    ],
    "competitors": [
        "PFE",
        "AMGN",
        "ABBV"
    ],
    "related_stocks": [
        "MRNA",
        "BMY",
        "GILD",
        "VRTX"
    ]
}